Last reviewed · How we verify

NCT04113954

Detecting Compartment Syndrome Pain in the Presence of Regional Anesthesia in Healthy Volunteers

Completed Phase 1 Last updated 14 May 2021
What this trial tests

Phase 1 trial testing Mepivacaine Injection in Compartment Syndrome of Leg in 42 participants. Completed in 6 April 2021.

Timeline
29 September 2020
Primary endpoint
6 April 2021
6 April 2021

Quick facts

Lead sponsorBrigham and Women's Hospital
PhasePhase 1
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingsingle
Primary purposebasic science
Enrollment42
Start date29 September 2020
Primary completion6 April 2021
Estimated completion6 April 2021
Sites1 location across United States

Drugs / interventions tested

Conditions studied

Sponsor

Brigham and Women's Hospital

Who can join

Adults 18 to 65, any sex, with Compartment Syndrome of Leg or Healthy. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The goal of the study is to determine how different types of Regional Anesthesia (nerve blocks) can be helpful to patients with lower extremity trauma who develop compartment syndrome (an increased pressure in the fascial compartments) which can occur after injury to the leg. This is a prospective, randomized study in healthy volunteers, who will undergo testing of the leg using a cuff inflation system, involving quantitative sensory testing (QST), questionnaire completion, with ultrasound scanning and nerve blocks in a supervised, monitored setting (BWH Clinical Investigation Center). Specific Aims 1. Determine the effect of adductor canal-saphenous nerve block (ACB) and popliteal-fossa nerve block (SNB-PF) vs no block on pressure and ischemic pain in a model of compartment syndrome. 1. Hypothesis: There will be minimal or no change in pressure pain threshold and tolerance and pain ratings with ACB alone 2. Hypothesis: There will be an increase in pressure pain threshold and tolerance and decrease in pain ratings with ACB plus popliteal-fossa nerve block (SNB-PF), compared to no block 2. Determine the concentration dependence of SNB-PF effect on pressure and ischemic pain by comparing increasing doses of local anesthetic. 1. Hypothesis: There will be a greater increase in pressure pain threshold and tolerance and great decrease in pain ratings with 1.5% mepivacaine than with 0.375% mepivacaine.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

  1. Impact of varying degrees of peripheral nerve blockade on experimental pressure and ischemic pain: adductor canal and sciatic nerve blocks in a human model of compartment syndrome pain.
    Chen YK, Lirk P, Flowers KM, Colebaugh CA, et al · · 2022 · cited 5× · PMID 35858717 · DOI 10.1136/rapm-2022-103671

Verify or expand the search:

Other trials of Mepivacaine Injection

Trials testing the same drug.

Other Brigham and Women's Hospital trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04113954.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing